Publications from IDPC Members

Results 805 to 816 of 1035
25 March 2012
Drug policy reform – From evidence to practice: Session report

Drug policy reform – From evidence to practice: Session report

The last of the series of Correlation Conferences, entitled ‘Getting out of the margins – Changing realities and making the difference’, took place from 12th to 14th December 2011 in Ljubljana, Slovenia. This report is an account of the discussions that took place during the final session of the Conference, ‘Drug policy reform – From evidence to practice’.
11 March 2012

Towards a revision of the UN drug control conventions: The logic and dilemmas of like-minded groups

Recent years have seen a growing unwillingness among increasing numbers of States parties to fully adhere to a strictly prohibitionist reading of the UN drug control conventions. Such behaviour has been driven by a belief that non-punitive and pragmatic health oriented domestic policy approaches that are in line with fundamental human rights standards better address the complexities surrounding illicit drug use than the zero-tolerance approach privileged by the present international treaties.
11 March 2012
The UN drug control conventions: The limits of latitude

The UN drug control conventions: The limits of latitude

This briefing paper outlines the international legal drug control obligations, the room for manoeuvre the regime leaves open to national policy makers and the clear limits of latitude that cannot be crossed without violating the treaties.
23 February 2012
Financing Dispossession - China’s Opium Substitution Programme in Northern Burma

Financing Dispossession - China’s Opium Substitution Programme in Northern Burma

The vast majority of the opium and heroin on the Chinese market originates from northern Burma. Apart from attempting to address domestic consumption problems, the Chinese government has also created a poppy substitution development programme, and has been actively promoting Chinese companies to take part, offering subsidies, tax waivers, and import quotas for Chinese companies.